24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
45.41% |
|
ALZHEIMERS |
43.24% |
|
CANCER |
8.65% |
|
ENZYME DYNAMICS |
2.7% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
50.6% |
|
ALZHEIMERS |
24.2% |
|
PEPTIDOMIMETIC CD40L BINDING |
24.1% |
|
ENZYME DYNAMICS |
1.1% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
30.41% |
|
CANCER |
25.95% |
|
PEPTIDOMIMETIC CD40L BINDING |
19.21% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
9.04% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
7.86% |
|
ALZHEIMERS |
5.4% |
|
ATSTP10 SUCROSE TRANSPORT |
1.24% |
|
ATSTP10 TRANSPORT SIMULATION |
.51% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.24% |
|
MEMBRANE TRANSPORT |
.14% |